Dietmar Berger

CIK 1739515 · Chief Medical Officer · last filed 2026-06-11

Dietmar Berger is a Chief Medical Officer who has filed 10 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for GILD, was dated Jun 11, 2026. Current disclosed insider exposure totals $2.9M across reported positions. 7 SEC filings were submitted jointly with GILEAD SCIENCES, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.94M

Companies

2

Total Filings

10

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY, CA 94404

Related Filers

GILEAD SCIENCES, INC. — 7 joint filings, latest 2026-06-11

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
GILD	Chief Medical Officer	19,252	$151.00	$2.91M	$0	6	2026-06-11
ATRA	Global Head of R&D	3,427	$9.76	$33.4K	$0	4	2019-05-08

Recent Filings

10 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-06-11	GILD	Mixed	+270	-$31.9K	EDGAR
2026-03-12	GILD	Mixed	+1,070	-$157.9K	EDGAR
2026-03-02	GILD	Grant (A)	+8,530	$0	EDGAR
2026-01-05	GILD	Mixed	+9,382	-$844.4K	EDGAR
2025-03-12	GILD	Grant (A)	—	$0	EDGAR
2025-01-03	GILD	Grant (A)	—	$0	EDGAR
2019-05-08	ATRA	Tax (F)	−4,322	-$144.6K	EDGAR
2019-03-27	ATRA	Grant (A)	+15,000	$0	EDGAR
2019-02-08	ATRA	Grant (A)	+25,000	$0	EDGAR
2018-05-07	ATRA	Grant (A)	+50,000	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.